Lansobene

Lansoprazole, the active ingredient in Lansobene, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is employed to treat conditions such as gastro‑esophageal reflux disease, peptic ulcers and ulcer prevention in patients taking NSAIDs.

GNH USA supplies Lansobene as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Our network includes regulatory support and after‑sales service to ensure seamless integration into healthcare supply chains.

Lansoprazole is indicated for several acid‑related gastrointestinal conditions. - Gastro‑esophageal reflux disease (GERD): alleviates heartburn and promotes healing of esophageal mucosa. - Peptic ulcer disease: facilitates ulcer healing by suppressing gastric acid secretion. - NSAID‑induced ulcer prophylaxis: reduces risk of ulcer formation in patients receiving non‑steroidal anti‑inflammatory drugs. - Helicobacter pylori eradication (in combination therapy): enhances eradication rates when used with antibiotics.

Lansoprazole may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache: mild, transient headache reported by some patients. - Diarrhea: loose stools or increased bowel movements. - Nausea: occasional feeling of queasiness or upset stomach.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis that can occur with prolonged use. - Interstitial nephritis: inflammation of kidney tissue requiring medical attention. - Severe allergic reaction: rash, swelling, or anaphylaxis necessitating immediate discontinuation.

When prescribing Lansobene, clinicians should consider several precautionary measures to ensure safe use. - Assess renal function: adjust therapy in patients with severe renal impairment. - Monitor magnesium levels: prolonged treatment may lead to hypomagnesemia. - Review drug hypersensitivity: discontinue if signs of allergic reaction appear. - Caution with anticoagulants: concurrent use may increase bleeding risk. - Store at ambient temperature: keep in the original container, protect from moisture.

Lansoprazole can interact with other medicines, affecting their efficacy or safety.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet activity may increase cardiovascular risk. - Atazanavir: decreased absorption leading to sub‑therapeutic antiviral levels.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR and bleeding tendency. - Methotrexate: elevated serum concentrations may cause toxicity. - Digoxin: possible rise in serum digoxin levels.